231 related articles for article (PubMed ID: 29659126)
1. Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers.
Haney M; Cooper ZD; Bedi G; Herrmann E; Comer SD; Reed SC; Foltin RW; Levin FR
Addict Biol; 2019 Jul; 24(4):707-716. PubMed ID: 29659126
[TBL] [Abstract][Full Text] [Related]
2. Use of Guanfacine for Cannabis Use Disorder and Related Symptomology.
Holst M; Mathai DS; Patel MM; Rodgman C; Keller J; Hussain MZ; De La Garza R; Kosten TR; Verrico CD
Am J Addict; 2019 Nov; 28(6):455-464. PubMed ID: 31483544
[TBL] [Abstract][Full Text] [Related]
3. Impact of cyclooxygenase-2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers.
Haney M; Bedi G; Cooper ZD; Herrmann ES; Reed SC; Foltin RW; Kingsley PJ; Marnett LJ; Patel S
Addict Biol; 2022 Jul; 27(4):e13183. PubMed ID: 35754107
[TBL] [Abstract][Full Text] [Related]
4. Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse.
Haney M; Hart CL; Vosburg SK; Comer SD; Reed SC; Foltin RW
Psychopharmacology (Berl); 2008 Mar; 197(1):157-68. PubMed ID: 18161012
[TBL] [Abstract][Full Text] [Related]
5. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.
Haney M; Cooper ZD; Bedi G; Vosburg SK; Comer SD; Foltin RW
Neuropsychopharmacology; 2013 Jul; 38(8):1557-65. PubMed ID: 23443718
[TBL] [Abstract][Full Text] [Related]
6. Marijuana withdrawal in humans: effects of oral THC or divalproex.
Haney M; Hart CL; Vosburg SK; Nasser J; Bennett A; Zubaran C; Foltin RW
Neuropsychopharmacology; 2004 Jan; 29(1):158-70. PubMed ID: 14560320
[TBL] [Abstract][Full Text] [Related]
7. A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers.
Cooper ZD; Foltin RW; Hart CL; Vosburg SK; Comer SD; Haney M
Addict Biol; 2013 Nov; 18(6):993-1002. PubMed ID: 22741619
[TBL] [Abstract][Full Text] [Related]
8. 5HT-2C agonist lorcaserin decreases cannabis self-administration in daily cannabis smokers.
Arout CA; Cooper ZD; Reed SC; Foltin RW; Comer SD; Levin FR; Haney M
Addict Biol; 2021 Jul; 26(4):e12993. PubMed ID: 33389797
[TBL] [Abstract][Full Text] [Related]
9. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.
Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
Psychopharmacology (Berl); 2016 Jul; 233(13):2469-78. PubMed ID: 27085870
[TBL] [Abstract][Full Text] [Related]
10. Bupropion SR worsens mood during marijuana withdrawal in humans.
Haney M; Ward AS; Comer SD; Hart CL; Foltin RW; Fischman MW
Psychopharmacology (Berl); 2001 May; 155(2):171-9. PubMed ID: 11401006
[TBL] [Abstract][Full Text] [Related]
11. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study.
Mathai DS; Holst M; Rodgman C; Haile CN; Keller J; Hussain MZ; Kosten TR; Newton TF; Verrico CD
J Neuropsychiatry Clin Neurosci; 2018; 30(1):66-76. PubMed ID: 28641496
[TBL] [Abstract][Full Text] [Related]
12. Guanfacine extended-release for cannabis use disorder: a pilot feasibility trial.
Dakwar E; Mahony A; Choi CJ; Pavlicova M; Brooks D; Mariani JP; Levin FR
Am J Drug Alcohol Abuse; 2020; 46(1):44-48. PubMed ID: 31339797
[No Abstract] [Full Text] [Related]
13. Nefazodone decreases anxiety during marijuana withdrawal in humans.
Haney M; Hart CL; Ward AS; Foltin RW
Psychopharmacology (Berl); 2003 Jan; 165(2):157-65. PubMed ID: 12439626
[TBL] [Abstract][Full Text] [Related]
14. Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse.
Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
Addict Biol; 2019 Jul; 24(4):765-776. PubMed ID: 30378231
[TBL] [Abstract][Full Text] [Related]
15. The marijuana withdrawal syndrome: diagnosis and treatment.
Haney M
Curr Psychiatry Rep; 2005 Oct; 7(5):360-6. PubMed ID: 16216154
[TBL] [Abstract][Full Text] [Related]
16. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration.
Schlienz NJ; Lee DC; Stitzer ML; Vandrey R
Drug Alcohol Depend; 2018 Jun; 187():254-260. PubMed ID: 29689485
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Withdrawal, Mood, and Sleep Inventories After Monitored 3-Week Abstinence in Cannabis-Using Adolescents and Young Adults.
Sullivan RM; Wallace AL; Stinson EA; Montoto KV; Kaiver CM; Wade NE; Lisdahl KM
Cannabis Cannabinoid Res; 2022 Oct; 7(5):690-699. PubMed ID: 34678051
[No Abstract] [Full Text] [Related]
18. Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse.
Haney M; Hart CL; Vosburg SK; Comer SD; Reed SC; Cooper ZD; Foltin RW
Psychopharmacology (Berl); 2010 Aug; 211(2):233-44. PubMed ID: 20521030
[TBL] [Abstract][Full Text] [Related]
19. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor IS
JAMA Psychiatry; 2014 Mar; 71(3):281-91. PubMed ID: 24430917
[TBL] [Abstract][Full Text] [Related]
20. Influence of tiagabine maintenance on cannabis effects and related behaviors in daily cannabis users.
Wesley MJ; Westgate PM; Stoops WW; Kelly TH; Hays LR; Lile JA
Exp Clin Psychopharmacol; 2018 Jun; 26(3):310-319. PubMed ID: 29863387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
